(Q43231168)

16 November 2017

title

Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol (English)

1 reference

16 November 2017

1 reference

5

Stefan Rutkowski

1 reference

16 November 2017

Johannes E A Wolff

1

1 reference

16 November 2017

Pablo Hernaiz Driever

2

1 reference

16 November 2017

Bernhard Erdlenbruch

3

1 reference

16 November 2017

Rolf D Kortmann

4

1 reference

16 November 2017

Torsten Pietsch

6

1 reference

16 November 2017

Crystal Parker

7

1 reference

16 November 2017

Monica Warmuth Metz

8

1 reference

16 November 2017

Astrid Gnekow

9

1 reference

16 November 2017

Christof M Kramm

10

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

16 November 2017

1 reference

16 November 2017

volume

116

1 reference

16 November 2017

issue

3

1 reference

16 November 2017

page(s)

705-712

1 reference

The 2007 WHO classification of tumours of the central nervous system

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

High-dose carmustine for high-grade gliomas in childhood.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Expression of p53 and prognosis in children with malignant gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Treatment options in childhood pontine gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Second temporal remission in a malignant glioma with trofosfamide and etoposide: a case report.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

[HIT-GBM: multicenter study of treatment of children with malignant glioma]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Treatment of paediatric pontine glioma with oral trophosphamide and etoposide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Interferon-gamma inhibits proliferation and adhesion of T98G human malignant glioma cells in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Influence of mesna on the pharmacokinetics of cisplatin and carboplatin in pediatric cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Valproic acid for the treatment of pediatric malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Valproic acid treatment of glioblastoma multiforme in a child

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Central neurocytoma responsive to topotecan, ifosfamide, carboplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Preradiation chemotherapy for pediatric patients with high-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot Study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Phenotypic and genotypic characterization of orthotopic human glioma models and its relevance for the study of anti-glioma therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24730

7 January 2021

Identifiers

DOI

10.1002/CNCR.24730

1 reference

16 November 2017

1 reference